Globus Medical (GMED) free cash flow

Free cash flow · fiscal 2025
$579.02M

Globus Medical (GMED) generated free cash flow of $579.02M in fiscal 2025 (the year ended December 31, 2025). That is 42.9% higher than the $405.21M of fiscal 2024. Figures as of 18 Nov 2026, 12:42 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Free cash flow, fiscal 2025
$579.02M
Change on fiscal 2024
+42.9%
Growth, 5 years
+33.8% a year
Growth, 10 years
+23.0% a year
Highest on record
$579.02Mfiscal 2025
Lowest on record
$51.84Mfiscal 2012
Fiscal years on record
162010–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Globus Medical free cash flow, in more detail

Over the five fiscal years to 2025 free cash flow grew at a compound 33.8% a year; over ten years the rate was 23.0% a year. Across the 16 fiscal years on record (2010–2025), the highest was $579.02M in fiscal 2025 and the lowest $51.84M in fiscal 2012.

History · 16 fiscal years

Free cash flow by fiscal year

Globus Medical free cash flow, year by year

Globus Medical (GMED) free cash flow by fiscal year
Fiscal yearFree cash flowChangeYear ended
2025$579.02M 42.9% up
2024$405.21M 145.2% up
2023$165.23M 58.2% up
2022$104.42M 52.4% down
2021$219.38M 62.3% up
2020$135.14M 33.5% up
2019$101.23M 17.0% down
2018$121.95M 13.2% up
2017$107.76M 0.8% up
2016$106.91M 46.0% up
2015$73.25M 34.6% up
2014$54.42M 22.0% down
2013$69.79M 34.6% up
2012$51.84M 3.9% down
2011$53.92M 8.6% down
2010$58.99M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement.

How to read it

It is the cash left for dividends, buybacks, debt repayment and acquisitions; profit that never turns into free cash flow deserves a second look.

Free cash flow at health care companies of similar size

Free cash flow of Globus Medical and comparable companies
CompanyFree cash flowFiscal year
Spyre Therapeutics SYRE-$169.25M2025
Qiagen QGEN$447.20M2025
Insulet PODD$349.90M2025
Bruker BRKR$13.90M2025
Globus Medical GMED$579.02M2025
Madrigal Pharmaceuticals MDGL-$193.02M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on GMED

Globus Medical, figure by figure

Globus Medical (GMED) overview: price, valuation and scorecardAll health care companies by market value

Globus Medical free cash flow: questions and answers

What is Globus Medical's free cash flow?

Globus Medical (GMED) generated free cash flow of $579.02M in fiscal 2025 (the year ended December 31, 2025). That is 42.9% higher than the $405.21M of fiscal 2024.

What is the growth rate of Globus Medical's free cash flow?

Over the five fiscal years to 2025 free cash flow grew at a compound 33.8% a year; over ten years the rate was 23.0% a year.

What are the highest and lowest free cash flow figures on record for Globus Medical?

Across the 16 fiscal years on record (2010–2025), the highest was $579.02M in fiscal 2025 and the lowest $51.84M in fiscal 2012.

How is Globus Medical's free cash flow calculated?

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement. For Globus Medical it is on record here for 16 fiscal years, 2010 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Globus Medical (GMED) free cash flow”, data as of 18 November 2026. https://funkfolio.com/stock/GMED/free-cash-flow

Underlying data: the company's filings with the SEC and Yahoo Finance.